Replies to post #197642 on Enzolytics Inc (ENZC)

[Valuator2]

Mutat, If you're asking about what IP went back to ENZC in the Novation, SAGA didn't specify anything, and I don't think ENZC has put out a PR about it yet. We all would like to know!
https://finance.yahoo.com/news/sagaliam-acquisition-corp-announces-novation-120000626.html?guce_referrer=aHR0cHM6Ly90LmNvLw&guce_referrer_sig=AQAAADFHcsh9wLllAx0AG-c48DZwQHRN7qYPPX7TEsIpag8GDFxMndrqqQ-yDM5PZxQgQpQC_NTZdsKbc3G_LwbrMS_4MXrF0k_P48KZpJONi22bF2yia0IXetmHu-GKEZdsz2bCeep19vBXh13wpZ0UO5aKjDvolYvWrZlTfjGLCymO&guccounter=2

This agreement transferred ownership of Biogenysis, Inc. ("BGEN") and it's IP, patents and associated asset being developed back to ENZC in exchange for a reduction of the price from $450,000,000 to $290,000,000 with the dividend of the purchase shares to come directly to the ENZC shareholders from SAGA.